Please login to the form below
Webinars
-
Wednesday, 13 July 2022 - 10:30 am
Agreeing sustainable value-based contracts with payers: myths and realitiesValue-based contracts (VBC) are increasingly considered by companies for many types of therapies. Some companies are suggesting that VBC will become the default for them across their portfolio.
Josie Godfrey, Malcom Qualie, Heather McDonald, John Pincher
FREE | REGISTER NOW
-
Thursday, 23 June 2022 - 3:00 pm
Diversity in Pharma: The Impact of COVID-19 on DE&ICOVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative.
Andrés López Castaño, Tricia Lucas-Clarke, Noor Shaker, Sandra Van de Cauter, Marsha N. Ganthier
FREE | VIEW NOW
-
Wednesday, 8 June 2022 - 3:00 pm
Accelerating patient recruitment in clinical trials post COVID-19Patient recruitment is arguably one of the most important aspects of a clinical trial. Without enough participants, trials will inevitably fail, meaning potentially effective therapies will not be brought to market.
Kate Shaw, Founder & CEO, Innovative Trials; Jane Thurston, Senior Patient Recruitment Lead, Parexel; Whitney Taynton, Business Unit Head, Innovative Trials
FREE WEBINAR | VIEW NOW
-
Thursday, 31 March 2022 - 3:00 pm
Smarter strategies: precise customer-centric digital engagement with the NHSHaving traditionally found itself near the bottom of digital adoption league tables, the scale and maturity of customer engagement practices within the pharmaceutical industry, accelerated by the COVID-19 pandemic, are now building at considerable pace.
Simon Grime: Digital Engagement Director, Wilmington Healthcare Tina White: Principal Clinical Consultant – Commissioning, Wilmington Healthcare Julian Snape: Commercial Optimisation Director, Wilmington Healthcare
FREE | VIEW NOW
-
Thursday, 24 February 2022 - 2:00 pm
Diversity in Clinical Trials : A more inclusive approach in patient recruitmentWe have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient recruitment.
Kate Shaw - Founder/CEO, Innovative Trials
FREE | VIEW NOW
-
Thursday, 20 January 2022 - 2:00 pm
After the wildfire: how will healthcare recover from the pandemic?Following a forest fire, the natural world recovers according to predictable patterns, in a process known as ‘ecological succession’. After the global conflagration of COVID-19, what will the equivalent patterns look like for health?
Langland, a Publicis Health Company
FREE | VIEW NOW
-
Wednesday, 7 November 2018 - 3:00 pm
Beyond the Blame Game: Improving Patient, Physician, Pharma RelationsWe often hear patients report a lack of ‘connection’ with their physician, and where lifestyle plays a role in the development of a disease, such as obesity or type 2 diabetes, patients may even feel the doctor blames them for their condition.
Andrew McConaghie, Group Editor
FREE | VIEW NOW
-
Thursday, 14 December 2017 - 2:00 pm
Transforming Access to Medicines Through Patient-Centric SolutionsAs medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 30 November 2017 - 2:00 pm
The Future of Marketing in Life Sciences: Is your function fit for purposeThe healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 15 November 2017 - 3:00 pm
The Power of Storytelling in Health: Friend or Foe?With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 19 October 2017 - 3:00 pm
The Truth about Doctors‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and how we can improve the way we communicate to them.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 10 October 2017 - 3:00 pm
Proving the Strategic Value of PatientsPatient insights aren’t just a ‘nice to have’: they are essential to understand the space where Pharma’s drugs ‘live’.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 11 July 2017 - 3:00 pm
Regret MinimisationWhen new products approach the market the level of demand for them is often exaggerated.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 19 April 2017 - 3:00 pm
Assessing early market opportunityTo successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 24 January 2017 - 3:00 pm
PC: Are you Patient Centric or just Politically Correct?Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Monday, 28 November 2016 - 3:00 pm
Communicating innovation to payers and policy makersInvolving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Thursday, 17 November 2016 - 3:00 pm
Immuno-oncology's evolution: implications for pharma market researcheImmuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Wednesday, 9 November 2016 - 2:00 pm
Scale & Strategy: Essential tools for transforming the commercial modelMost life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 25 October 2016 - 3:00 pm
Driving adoption of Commercial Analytic solutionsMeasuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.
Dominic Tyer, Editorial director
FREE | VIEW NOW
-
Tuesday, 4 October 2016 - 3:00 pm
Modelling ‘smart’ and ‘lazy’ thinking to influence decision-makingTraditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.
Dominic Tyer, Editorial director
FREE | VIEW NOW
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Biogen and Happify Health team up to create digital platform for MS patients
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Moderna to launch Innovation and Technology Center in the UK
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- In recognition of the Anniversary of Stonewall, Nucleus Global brings attention and awareness to persistent health care inequities experienced by LGBTQIA+
- The Evolving Role of the Sales Rep
- Measure your omnichannel maturity with our new tool
- Report: Omnichannel advice for the life science industry
- Gilead Sciences supports Kigali Declaration for neglected tropical diseases
- As the NHS turns 74, it launches its ‘biggest NHS Big Tea ever’ to raise funds
- Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Almirall shares positive topline results from atopic dermatitis trials
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Report: Omnichannel advice for the life science industry
- In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...
